Lead Product(s) : Pantoprazole Sodium,Domperidone
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Royal Sense Launches Multiple Products in Pharmaceutical Category
Details : OPENTOP D (pantoprazole Sodium and domperidone) Delayed-Release tablets are indicated for short-term treatment of Erosive Esophagitis Associated with GERD.
Product Name : Opentop D
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 28, 2024
Lead Product(s) : Pantoprazole Sodium,Domperidone
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Domperidone
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of GERDOFF Efficacy in Combination With Proton Pump Inhibitor
Details : Domperidone is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Gastroesophageal Reflux.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 04, 2019
Lead Product(s) : Domperidone
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Domperidone
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Domperidone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Dyspepsia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 06, 2018
Lead Product(s) : Domperidone
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Domperidone
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Domperidone is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 29, 2016
Lead Product(s) : Domperidone
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Domperidone
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Domperidone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Gastroenteritis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 04, 2016
Lead Product(s) : Domperidone
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Domperidone
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Alberta Innovates Health Solutions
Deal Size : Inapplicable
Deal Type : Inapplicable
Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS)
Details : Domperidone is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Multiple Sclerosis, Relapsing-Remitting.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 09, 2015
Lead Product(s) : Domperidone
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Alberta Innovates Health Solutions
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Domperidone
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Alberta Innovates Health Solutions
Deal Size : Inapplicable
Deal Type : Inapplicable
Domperidone in Secondary Progressive Multiple Sclerosis (SPMS)
Details : Domperidone is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Multiple Sclerosis, Chronic Progressive.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 04, 2014
Lead Product(s) : Domperidone
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Alberta Innovates Health Solutions
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Domperidone
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Healthy Volunteers
Details : Domperidone is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 18, 2012
Lead Product(s) : Domperidone
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Domperidone
Therapeutic Area : Gastroenterology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
The Use of Domperidone for Gastroparesis
Details : Domperidone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Gastroparesis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 23, 2011
Lead Product(s) : Domperidone
Therapeutic Area : Gastroenterology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
